Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Current Treatment Guidelines for Schizophrenia
Panelists discuss how evidence-based, patient-tailored guideline adherence enhances long-term schizophrenia outcomes.
EP: 1.Clinical and Economic Burden of Schizophrenia
EP: 2.Symptoms Associated with Schizophrenia
EP: 3.Risk Factors for Schizophrenia
EP: 4.Challenges of Early and Accurate Diagnosis in Schizophrenia
EP: 5.Exploring Schizophrenia Progression and Its Impact on Quality of Life
EP: 6.Consequences of Relapse in Schizophrenia Care
EP: 7.Addressing Social Determinants of Health and Unmet Needs in Schizophrenia
Now Viewing
EP: 8.Current Treatment Guidelines for Schizophrenia
EP: 9.First- and Second-Generation Antipsychotic Therapies and Treatment Sequencing
EP: 10.Switching Therapies, Managing Adverse Effects, and Adherence Challenges
EP: 11.Xanomeline/Trospium Mechanism of Action, Efficacy, and Safety
EP: 12.Use of Xanomeline/Trospium in Clinical Practice
EP: 13.Comparing Safety Profiles and Health Care Costs
EP: 14.Emerging Therapies in Schizophrenia
EP: 15.Addressing Access Barriers and Formulary Restrictions
EP: 16.Final Thoughts on Improving Access and Care
Panelists discuss how the latest APA guidelines advocate a multimodal approach combining pharmacologic treatment with psychosocial interventions such as cognitive-behavioral therapy and supported employment.
Panelists discuss how adherence, monitoring of adverse effects, and collaborative care are emphasized as pillars of sustained stability. Clinicians are encouraged to adapt evidence-based strategies to individual patient profiles.
Panelists discuss how guideline adherence improves outcomes, but flexibility is required to tailor interventions to patients’ unique needs, comorbidities, and cultural contexts.
Related Videos
Related Content
